- Home
- SKYQ vs XAIR Comparison
SKYQ vs XAIR Comparison
Compare SKYQ & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYQ
- XAIR
- Stock Information
- Founded
- SKYQ 2019
- XAIR 2011
- Country
- SKYQ United States
- XAIR United States
- Employees
- SKYQ N/A
- XAIR N/A
- Industry
- SKYQ
- XAIR Medical/Dental Instruments
- Sector
- SKYQ
- XAIR Health Care
- Exchange
- SKYQ NYSE
- XAIR Nasdaq
- Market Cap
- SKYQ 26.1M
- XAIR 26.0M
- IPO Year
- SKYQ N/A
- XAIR N/A
- Fundamental
- Price
- SKYQ $1.25
- XAIR $0.42
- Analyst Decision
- SKYQ
- XAIR Strong Buy
- Analyst Count
- SKYQ 0
- XAIR 4
- Target Price
- SKYQ N/A
- XAIR $3.67
- AVG Volume (30 Days)
- SKYQ 301.4K
- XAIR 2.3M
- Earning Date
- SKYQ 02-14-2025
- XAIR 02-10-2025
- Dividend Yield
- SKYQ N/A
- XAIR N/A
- EPS Growth
- SKYQ N/A
- XAIR N/A
- EPS
- SKYQ N/A
- XAIR N/A
- Revenue
- SKYQ $30,766,012.00
- XAIR $2,342,000.00
- Revenue This Year
- SKYQ N/A
- XAIR $230.80
- Revenue Next Year
- SKYQ N/A
- XAIR $265.55
- P/E Ratio
- SKYQ N/A
- XAIR N/A
- Revenue Growth
- SKYQ N/A
- XAIR 685.91
- 52 Week Low
- SKYQ $0.82
- XAIR $0.30
- 52 Week High
- SKYQ $5.49
- XAIR $2.17
- Technical
- Relative Strength Index (RSI)
- SKYQ N/A
- XAIR 51.29
- Support Level
- SKYQ N/A
- XAIR $0.34
- Resistance Level
- SKYQ N/A
- XAIR $0.38
- Average True Range (ATR)
- SKYQ 0.00
- XAIR 0.06
- MACD
- SKYQ 0.00
- XAIR 0.00
- Stochastic Oscillator
- SKYQ 0.00
- XAIR 40.62
About SKYQ SKY QUARRY INC
Sky Quarry Inc is a development-stage oil-producing and refining company. The company along with its subsidiaries is engaged in deploying technologies to facilitate the recycling of waste asphalt shingles and remediation of oil-saturated soils. The recycling and production of oil from asphalt shingles is expected to reduce the dependence on landfills for the disposal of waste and to also reduce dependence on foreign and domestic virgin crude oil extraction for industrial uses.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.